InteliFUSE and Biomedical Enterprise Patent Dispute Over Orthopedic Device Settled

The U.S. District Court Judge has ordered a Stipulation of Dismissal for the patent infringement case between InteliFUSE and Biomedical Enterprises following a settlement for an undisclosed amount, according to a company news release.

Advertisement

InteliFUSE, a New Orleans-based orthopedic surgical device manufacturer that markets StimuLINK, accused Biomedical Enterprises of patent infringement. Under the settlement, the InteliFUSE patents under question were acknowledged as valid and enforceable patents.

The StimuLINK is a shape memory mini-implant designed for use in many orthopedic indications, including surgeries of the foot, ankle, hand and wrist. The device replaces plates, screws, rods, nails and wires.

Read the InteliFUSE news release on the patent infringement settlement.

Read other coverage on patent infringement cases:

– NuVasive Initiates Patent Infringement Lawsuit Against Globus Medical

– Stryker Files Patent Infringement Lawsuit Against Zimmer Holdings

– NuVasive Settles Patent Dispute With Orthofix, Includes $2M Settlement

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in Spinal Tech

  • Since March 25, there have been two key developments in lawsuits involving spine medtech companies. 1. The U.S. Court of…

  • The highest-paid CFOs at spine and orthopedic medtech companies saw total compensation reaching in the mid-single digits and beyond. Here…

Advertisement

Comments are closed.